Lobbying disclosures · Lobbying report
CAH: third_quarter 2026 lobbying report
Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation. Issues related to tariffs, trade, and U.S. trade policy. Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, and reimbursement to home healthcare agencies. Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, pharmacy services administrative organizations; Issues related to prov
Follow CAH- Became public
- Oct 20, 2026, 1:54 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 11, 2026, 4:37 PM EST
Why this is connected
Exact legal-name match: CARDINAL HEALTH INC (https://www.sec.gov/Archives/edgar/data/721371/).
Reported lobbying amounts
Expenses: $400,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/a6ff9ec2-1ac2-45a1-a0b2-de9be14e616a/","filing_uuid":"a6ff9ec2-1ac2-45a1-a0b2-de9be14e616a","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/a6ff9ec2-1ac2-45a1-a0b2-de9be14e616a/print/","filing_document_content_type":"text/html","income":null,"expenses":"400000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Rebecca McGrath","dt_posted":"2026-10-20T13:54:42-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"7000 CARDINAL PLACE","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"DUBLIN","registrant_state":"OH","registrant_zip":"43017","registrant":{"id":58055,"url":"https://lda.gov/api/v1/registrants/58055/","house_registrant_id":35261,"name":"CARDINAL HEALTH, INC.","description":null,"address_1":"7000 CARDINAL PLACE","address_2":null,"address_3":null,"address_4":null,"city":"DUBLIN","state":"OH","state_display":"Ohio","zip":"43017","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"REBECCA MCGRATH","contact_telephone":"+1 202-258-3789","dt_updated":"2026-07-30T08:49:35.442205-04:00"},"client":{"id":160433,"url":"https://lda.gov/api/v1/clients/160433/","client_id":12,"name":"CARDINAL HEALTH INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"OH","state_display":"Ohio","country":"US","country_display":"United States of America","ppb_state":"OH","ppb_state_display":"Ohio","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-13"},"lobbying_activities":[{"general_issue_code":"MAN","general_issue_code_display":"Manufacturing","description":"Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64174,"prefix":null,"prefix_display":null,"first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"MCGRATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138467,"prefix":"ms","prefix_display":"MS.","first_name":"ANGELEINE","nickname":null,"middle_name":null,"last_name":"COMTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140381,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"BARNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155609,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"HEALEY","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues related to tariffs, trade, and U.S. trade policy.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64174,"prefix":null,"prefix_display":null,"first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"MCGRATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138467,"prefix":"ms","prefix_display":"MS.","first_name":"ANGELEINE","nickname":null,"middle_name":null,"last_name":"COMTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140381,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"BARNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155609,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"HEALEY","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":22,"name":"U.S. Trade Representative (USTR)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, and reimbursement to home healthcare agencies.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64174,"prefix":null,"prefix_display":null,"first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"MCGRATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138467,"prefix":"ms","prefix_display":"MS.","first_name":"ANGELEINE","nickname":null,"middle_name":null,"last_name":"COMTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140381,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"BARNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155609,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"HEALEY","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164, Ensuring Community Access to Pharmacist Services Act; S. 2426, Equitable Community Access to Pharmacist Services Act, Education around issues facing independent physicians, including, S.3822, the Break Up Big Medicine Act, and H.R. 10444, Stop Corporate Takeovers of Physicians Act of 2026.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64174,"prefix":null,"prefix_display":null,"first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"MCGRATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138467,"prefix":"ms","prefix_display":"MS.","first_name":"ANGELEINE","nickname":null,"middle_name":null,"last_name":"COMTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140381,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"BARNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155609,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"HEALEY","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in CAH
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Oct 28, 2025$1K–$15K
Rep. Marjorie Taylor Greene (R-GA-14)
$1K–$15K · Traded Oct 24, 2025 · disclosed Oct 28, 2025
- May 19, 2025$1K–$15K
Rep. Marjorie Taylor Greene (R-GA-14)
$1K–$15K · Traded May 14, 2025 · disclosed May 19, 2025
- May 8, 2025$1K–$15K
Rep. Robert P. Bresnahan, Jr. (R-PA-8)
$1K–$15K · Traded Apr 8, 2025 · disclosed May 8, 2025
- May 6, 2025$1K–$15K
Rep. Marjorie Taylor Greene (R-GA-14)
$1K–$15K · Traded May 5, 2025 · disclosed May 6, 2025
- Mar 19, 2025$1K–$15K
Rep. Marjorie Taylor Greene (R-GA-14)
$1K–$15K · Traded Mar 17, 2025 · disclosed Mar 19, 2025
- Jan 27, 2025$1K–$15K
Rep. Marjorie Taylor Greene (R-GA-14)
$1K–$15K · Traded Jan 21, 2025 · disclosed Jan 27, 2025
- Sep 23, 2024$1K–$15K
Rep. Marjorie Taylor Greene (R-GA-14)
$1K–$15K · Traded Sep 20, 2024 · disclosed Sep 23, 2024
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.